Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male Volunteers
- First Posted Date
- 2012-09-07
- Last Posted Date
- 2012-11-08
- Lead Sponsor
- Astellas Pharma Canada, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT01681134
- Locations
- 🇨🇦
INC Research, Toronto, Ontario, Canada
News
No news found